Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies Inc.
TRADE NEWS: Agilent Technologies Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity
May 29th, 2009
Agilent Technologies Inc. (NYSE:A) announced that a major expansion of its Nucleic Acids Solutions Division (NASD) is complete, enabling the company to manufacture several hundred kilograms of therapeutic oligonucleotides per year. This production capacity allows Agilent to meet customers’ supply needs from preclinical and clinical studies through commercial launch. Oligonucleotide therapeutics is one of the fastest growing segments in drug development, and NASD’s products are used by biopharmaceutical companies at all stages of drug development. NASD now offers a full range of manufacturing capacities for flexible, cost-efficient production from grams to hundreds of...
Source: Health Business Week (2009-05-29)
|
